1. Home
  2. STVN vs FSK Comparison

STVN vs FSK Comparison

Compare STVN & FSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$15.43

Market Cap

4.2B

ML Signal

HOLD

Logo FS KKR Capital Corp.

FSK

FS KKR Capital Corp.

HOLD

Current Price

$10.32

Market Cap

4.2B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
STVN
FSK
Founded
1949
2007
Country
Italy
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Investment Managers
Sector
Consumer Discretionary
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
4.2B
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
STVN
FSK
Price
$15.43
$10.32
Analyst Decision
Buy
Hold
Analyst Count
3
8
Target Price
$25.67
$13.94
AVG Volume (30 Days)
524.4K
4.8M
Earning Date
01-01-0001
05-06-2026
Dividend Yield
0.40%
19.40%
EPS Growth
N/A
N/A
EPS
N/A
0.04
Revenue
N/A
N/A
Revenue This Year
$10.26
N/A
Revenue Next Year
$10.02
N/A
P/E Ratio
$27.15
$259.50
Revenue Growth
N/A
N/A
52 Week Low
$13.91
$10.04
52 Week High
$28.00
$22.68

Technical Indicators

Market Signals
Indicator
STVN
FSK
Relative Strength Index (RSI) 47.22 26.87
Support Level $14.03 $10.28
Resistance Level $17.14 $16.05
Average True Range (ATR) 0.83 0.45
MACD 0.08 -0.03
Stochastic Oscillator 38.75 13.27

Price Performance

Historical Comparison
STVN
FSK

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About FSK FS KKR Capital Corp.

FS KKR Capital Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The company's investment objectives are to generate current income and, to a lesser extent, long-term capital appreciation. The company's portfolio is comprised of investments in senior secured loans and second lien secured loans of private middle market U.S. companies and, to a lesser extent, subordinated loans and certain asset-based financing loans of private U.S. companies.

Share on Social Networks: